• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚昆士兰州癌症幸存者的长期健康服务费用:基于人群水平数据链接研究(Cos-Q)的结果。

Cancer Survivors' Long-Term Health Service Costs in Queensland, Australia: Results of a Population-Level Data Linkage Study (Cos-Q).

机构信息

School of Health and Behavioural Sciences, University of the Sunshine Coast, Maroochydore, QLD 4558, Australia.

Sunshine Coast Health Institute, Birtinya, QLD 4575, Australia.

出版信息

Int J Environ Res Public Health. 2022 Aug 2;19(15):9473. doi: 10.3390/ijerph19159473.

DOI:10.3390/ijerph19159473
PMID:35954835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9368477/
Abstract

Worldwide, the number of cancer survivors is rapidly increasing. The aim of this study was to quantify long-term health service costs of cancer survivorship on a population level. The study cohort comprised residents of Queensland, Australia, diagnosed with a first primary malignancy between 1997 and 2015. Administrative databases were linked with cancer registry records to capture all health service utilization. Health service costs between 2013-2016 were analyzed using a bottom-up costing approach. The cumulative mean annual healthcare expenditure (2013-2016) for the cohort of N = 230,380 individuals was AU$3.66 billion. The highest costs were incurred by patients with a history of prostate (AU$538 m), breast (AU$496 m) or colorectal (AU$476 m) cancers. Costs by time since diagnosis were typically highest in the first year after diagnosis and decreased over time. Overall mean annual healthcare costs per person (2013-2016) were AU$15,889 (SD: AU$25,065) and highest costs per individual were for myeloma (AU$45,951), brain (AU$30,264) or liver cancer (AU$29,619) patients. Our results inform policy makers in Australia of the long-term health service costs of cancer survivors, provide data for economic evaluations and reinforce the benefits of investing in cancer prevention.

摘要

全球范围内,癌症幸存者的数量正在迅速增加。本研究旨在量化癌症生存者在人群层面上的长期卫生服务成本。研究队列包括澳大利亚昆士兰州在 1997 年至 2015 年间被诊断出患有第一原发性恶性肿瘤的居民。通过链接行政数据库和癌症登记记录来获取所有卫生服务利用情况。使用自下而上的成本核算方法分析了 2013-2016 年的卫生服务成本。队列中 230380 人的累计年平均医疗保健支出(2013-2016 年)为 36.6 亿澳元。有前列腺癌(5.38 亿澳元)、乳腺癌(4.96 亿澳元)或结直肠癌(4.76 亿澳元)病史的患者的花费最高。通常情况下,自诊断以来的时间成本在诊断后的第一年最高,随着时间的推移而降低。2013-2016 年每人的平均年医疗保健费用为 15889 澳元(标准差:25065 澳元),个人费用最高的是骨髓瘤(45951 澳元)、脑癌(30264 澳元)或肝癌(29619 澳元)患者。我们的研究结果为澳大利亚的政策制定者提供了癌症幸存者的长期卫生服务成本信息,为经济评估提供了数据,并强调了投资癌症预防的好处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/1ace6c0ca522/ijerph-19-09473-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/468311129e1c/ijerph-19-09473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/bde036d81d63/ijerph-19-09473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/347cc06aab2e/ijerph-19-09473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/e38f68929ab2/ijerph-19-09473-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/ae73cef64c28/ijerph-19-09473-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/8bb48971f8a1/ijerph-19-09473-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/6c7ab404db34/ijerph-19-09473-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/7c6342c2916b/ijerph-19-09473-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/1ace6c0ca522/ijerph-19-09473-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/468311129e1c/ijerph-19-09473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/bde036d81d63/ijerph-19-09473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/347cc06aab2e/ijerph-19-09473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/e38f68929ab2/ijerph-19-09473-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/ae73cef64c28/ijerph-19-09473-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/8bb48971f8a1/ijerph-19-09473-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/6c7ab404db34/ijerph-19-09473-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/7c6342c2916b/ijerph-19-09473-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b406/9368477/1ace6c0ca522/ijerph-19-09473-g009.jpg

相似文献

1
Cancer Survivors' Long-Term Health Service Costs in Queensland, Australia: Results of a Population-Level Data Linkage Study (Cos-Q).澳大利亚昆士兰州癌症幸存者的长期健康服务费用:基于人群水平数据链接研究(Cos-Q)的结果。
Int J Environ Res Public Health. 2022 Aug 2;19(15):9473. doi: 10.3390/ijerph19159473.
2
Factors impacting hospitalisation and related health service costs in cancer survivors in Australia: Results from a population data linkage study in Queensland (COS-Q).澳大利亚癌症幸存者住院和相关医疗服务费用的影响因素:昆士兰州人群数据链接研究的结果(COS-Q)。
Cancer Med. 2024 Sep;13(17):e70201. doi: 10.1002/cam4.70201.
3
Lifetime Costs of Surviving Cancer-A Queensland Study (COS-Q): Protocol of a Large Healthcare Data Linkage Study.《昆士兰癌症生存者终生成本研究(COS-Q):一项大型医疗保健数据链接研究方案》。
Int J Environ Res Public Health. 2020 Apr 20;17(8):2831. doi: 10.3390/ijerph17082831.
4
Quantifying the Costs to Different Funders over Five-Years for Women Diagnosed with Breast Cancer in Queensland, Australia: A Data Linkage Study.量化澳大利亚昆士兰州被诊断患有乳腺癌的女性在五年内对不同资助者的成本:一项数据链接研究。
Int J Environ Res Public Health. 2021 Dec 8;18(24):12918. doi: 10.3390/ijerph182412918.
5
What are the costs associated with child and maternal healthcare within Australia? A study protocol for the use of data linkage to identify health service use, and health system and patient costs.澳大利亚儿童和孕产妇医疗保健的相关成本有哪些?一项关于使用数据链接来确定医疗服务使用情况以及卫生系统和患者成本的研究方案。
BMJ Open. 2018 Feb 6;8(2):e017816. doi: 10.1136/bmjopen-2017-017816.
6
Health services costs for cancer care in Australia: Estimates from the 45 and Up Study.澳大利亚癌症护理的卫生服务费用:来自 45 岁及以上研究的估计。
PLoS One. 2018 Jul 30;13(7):e0201552. doi: 10.1371/journal.pone.0201552. eCollection 2018.
7
Quantifying Queensland patients with cancer health service usage and costs: study protocol.量化昆士兰癌症患者的医疗服务使用情况及费用:研究方案
BMJ Open. 2017 Jan 24;7(1):e014030. doi: 10.1136/bmjopen-2016-014030.
8
Resource use and costs associated with epilepsy in the Queensland hospital system: protocol for a population-based data linkage study.昆士兰州医院系统中癫痫相关的资源利用和成本:一项基于人群的数据分析研究方案。
BMJ Open. 2021 Dec 7;11(12):e050070. doi: 10.1136/bmjopen-2021-050070.
9
Out-of-pocket medical expenses compared across five years for patients with one of five common cancers in Australia.澳大利亚五种常见癌症患者五年间自付医疗费用比较。
BMC Cancer. 2021 Sep 25;21(1):1055. doi: 10.1186/s12885-021-08756-x.
10
The patient co-payment and opportunity costs of accessing healthcare for Indigenous Australians with cancer: A whole of population data linkage study.澳大利亚原住民癌症患者的医疗自付费用及就医机会成本:一项全人群数据关联研究。
Asia Pac J Clin Oncol. 2019 Dec;15(6):309-315. doi: 10.1111/ajco.13180. Epub 2019 Jul 16.

引用本文的文献

1
One-year longitudinal association between changes in aortic regional morphology and muscle mass in cancer.癌症患者主动脉局部形态变化与肌肉量之间的一年期纵向关联。
Sci Rep. 2025 Jul 1;15(1):22130. doi: 10.1038/s41598-025-06189-1.
2
Factors influencing the cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia in Australia.影响澳大利亚巴雷特食管伴低级别异型增生患者射频消融术成本效益的因素。
Dis Esophagus. 2025 Jan 7;38(1). doi: 10.1093/dote/doae095.
3
Factors impacting hospitalisation and related health service costs in cancer survivors in Australia: Results from a population data linkage study in Queensland (COS-Q).

本文引用的文献

1
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.2010 年至 2019 年 29 种癌症的发病率、死亡率、生命损失年数、失能生存年数和伤残调整生命年:2019 年全球疾病负担研究的系统分析。
JAMA Oncol. 2022 Mar 1;8(3):420-444. doi: 10.1001/jamaoncol.2021.6987.
2
First-Year Healthcare Resource Utilization Costs of Five Major Cancers in Japan.日本五种主要癌症的第一年医疗资源利用成本。
Int J Environ Res Public Health. 2021 Sep 7;18(18):9447. doi: 10.3390/ijerph18189447.
3
澳大利亚癌症幸存者住院和相关医疗服务费用的影响因素:昆士兰州人群数据链接研究的结果(COS-Q)。
Cancer Med. 2024 Sep;13(17):e70201. doi: 10.1002/cam4.70201.
4
Healthcare costs of cancer among children, adolescents, and young adults: A scoping review.儿童、青少年和青年癌症患者的医疗费用:范围综述。
Cancer Med. 2024 Feb;13(3):e6925. doi: 10.1002/cam4.6925. Epub 2024 Jan 12.
5
DAta Linkage to Enhance Cancer Care (DaLECC): Protocol of a Large Australian Data Linkage Study.数据链接以增强癌症护理(DaLECC):一项大型澳大利亚数据链接研究的方案。
Int J Environ Res Public Health. 2023 May 29;20(11):5987. doi: 10.3390/ijerph20115987.
6
Financial Toxicity and Out-of-Pocket Costs for Patients with Head and Neck Cancer.头颈部癌症患者的财务毒性和自付费用。
Curr Oncol. 2023 May 10;30(5):4922-4935. doi: 10.3390/curroncol30050371.
The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study.
欧洲结直肠癌的经济负担:一项基于人群的疾病成本研究。
Lancet Gastroenterol Hepatol. 2021 Sep;6(9):709-722. doi: 10.1016/S2468-1253(21)00147-3. Epub 2021 Jul 28.
4
Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective.土耳其肺癌的经济负担:从支付方角度进行的疾病成本研究。
Health Econ Rev. 2021 Jun 26;11(1):22. doi: 10.1186/s13561-021-00322-2.
5
Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis.按诊断时的分期计算美国医疗保险计划乳腺癌治疗的长期成本。
Eur J Health Econ. 2021 Dec;22(9):1365-1370. doi: 10.1007/s10198-021-01315-y. Epub 2021 May 18.
6
Acute and late side-effects after low dose-rate brachytherapy for prostate cancer; incidence, management and technical considerations.低剂量率近距离治疗前列腺癌的急性和晚期副作用;发生率、处理和技术考虑。
Brachytherapy. 2021 Sep-Oct;20(5):956-965. doi: 10.1016/j.brachy.2021.03.014. Epub 2021 May 8.
7
Estimated Costs and Long-term Outcomes of Patients With High-Risk Non-Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health System.退伍军人事务部医疗体系中,卡介苗治疗高危非肌肉浸润性膀胱癌患者的预估费用和长期结果。
JAMA Netw Open. 2021 Mar 1;4(3):e213800. doi: 10.1001/jamanetworkopen.2021.3800.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review.加拿大癌症护理的间接成本负担:系统文献综述。
Appl Health Econ Health Policy. 2021 May;19(3):325-341. doi: 10.1007/s40258-020-00619-z. Epub 2020 Dec 24.
10
Late side effects of radiation treatment for head and neck cancer.头颈部癌放射治疗的晚期副作用。
Radiat Oncol J. 2020 Jun;38(2):84-92. doi: 10.3857/roj.2020.00213. Epub 2020 Jun 25.